WealthShield Partners LLC grew its holdings in shares of Vanguard Value ETF (NYSEARCA:VTV – Get Rating) by 21.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 116,949 shares of the company’s stock after purchasing an additional 20,555 shares during the period. Vanguard Value ETF makes up approximately 2.9% of WealthShield Partners LLC’s investment portfolio, making the stock its 4th largest holding. WealthShield Partners LLC’s holdings in Vanguard Value ETF were worth $14,441,000 as of its most recent filing with the SEC.
A number of other large investors also recently modified their holdings of VTV. Darrow Company Inc. acquired a new position in shares of Vanguard Value ETF during the second quarter valued at $25,000. Horizons Wealth Management acquired a new position in Vanguard Value ETF during the second quarter worth about $30,000. Morton Brown Family Wealth LLC acquired a new position in Vanguard Value ETF during the second quarter worth about $34,000. John W. Brooker & Co. CPAs grew its holdings in Vanguard Value ETF by 42.2% during the third quarter. John W. Brooker & Co. CPAs now owns 273 shares of the company’s stock worth $34,000 after acquiring an additional 81 shares during the period. Finally, Arrow Financial Corp acquired a new position in Vanguard Value ETF during the second quarter worth about $35,000.
Vanguard Value ETF Stock Up 0.0 %
NYSEARCA:VTV opened at $142.65 on Wednesday. The business’s 50-day moving average price is $142.34 and its 200 day moving average price is $137.35. Vanguard Value ETF has a 52-week low of $122.54 and a 52-week high of $151.89.
Vanguard Value ETF Company Profile
Vanguard Value ETF (the Fund) is an exchange-traded share class of Vanguard Value Index Fund, which employs a passive management or indexing investment approach designed to track the performance of the MSCI US Prime Market Value Index (the Index). The Index is a diversified index of value stocks of predominantly large United States companies.
- Get a free copy of the StockNews.com research report on Vanguard Value ETF (VTV)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Vanguard Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.